Hims & Hers Health Sees Q3 Sales $880.000M-$900.000M vs $793.071M Est

Benzinga Newsdesk www.benzinga.com Positive 81.6%

Neg 0% Neu 0% Pos 81.6%

Hims & Hers Health (NYSE:HIMS) sees Q3 sales of $880.000 million-$900.000 million vs $793.071 million analyst estimate.

Comments

No comments yet. Be the first!